相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Treatment with Empagliflozin Attenuates Renal Damage in Obese Zucker Rat
Nandini D. P. K. Manne et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2020)
Effect of Empagliflozin, a Selective Sodium-Glucose Cotransporter 2 Inhibitor, on Kidney and Peripheral Nerves in Streptozotocin-Induced Diabetic Rats
Kyung Ae Lee et al.
DIABETES & METABOLISM JOURNAL (2018)
Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus
Hiroyuki Tanaka et al.
ADVANCES IN THERAPY (2017)
Hypercalcemia induces targeted autophagic degradation of aquaporin-2 at the onset of nephrogenic diabetes insipidus
Sookkasem Khositseth et al.
KIDNEY INTERNATIONAL (2017)
Sodium-glucose cotransporter 2 (SGLT2) inhibitors and fracture risk in patients with type 2 diabetes mellitus: A meta-analysis
Darin Ruanpeng et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
A Quantitative Systems Physiology Model of Renal Function and Blood Pressure Regulation: Model Description
K. M. Hallow et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome
Erik J. M. van Bommel et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Defective Store-Operated Calcium Entry Causes Partial Nephrogenic Diabetes Insipidus
Mykola Mamenko et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
No Need to Sugarcoat the Message: Is Cardiovascular Risk Reduction From SGLT2 Inhibition Related to Natriuresis?
Bruce A. Perkins et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Effect of Dapagliflozin Treatment on Fluid and Electrolyte Balance in Diabetic Rats
Ling Chen et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2016)
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications
Hiddo J. L. Heerspink et al.
CIRCULATION (2016)
Sodium-glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresis
Harindra Rajasekeran et al.
KIDNEY INTERNATIONAL (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure
James W. Reed
VASCULAR HEALTH AND RISK MANAGEMENT (2016)
Tolvaptan in Patients Hospitalized With Acute Heart Failure Rationale and Design of the TACTICS and the SECRET of CHF Trials
G. Michael Felker et al.
CIRCULATION-HEART FAILURE (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Possible adverse effects of SGLT2 inhibitors on bone
Simeon I. Taylor et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Integrated Control of Na Transport along the Nephron
Lawrence G. Palmer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Cyclophosphamide-induced vasopressin-independent activation of aquaporin-2 in the rat kidney
Sua Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Tissue-engineered kidney disease models
Teresa M. DesRochers et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z. I. Cherney et al.
CIRCULATION (2014)
Apelin Counteracts Vasopressin-Induced Water Reabsorption via Cross Talk Between Apelin and Vasopressin Receptor Signaling Pathways in the Rat Collecting Duct
Annette Hus-Citharel et al.
ENDOCRINOLOGY (2014)
A Protein Kinase A-Independent Pathway Controlling Aquaporin 2 Trafficking as a Possible Cause for the Syndrome of Inappropriate Antidiuresis Associated with Polycystic Kidney Disease 1 Haploinsufficiency
Grazia Tamma et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling
Yu Ah Hong et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes
T. Heise et al.
DIABETES OBESITY & METABOLISM (2013)
Regulation of aquaporin-2in the kidney: A molecular mechanism of body-water homeostasis
Tae-Hwan Kwon et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2013)
Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat
Scott C. Thomson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2012)
Molecular biology of water and salt regulation in the kidney
C. Esteva-Font et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Renal calcium, phosphorus, magnesium and uric acid handling: comparison between stage III chronic kidney disease patients and healthy oldest old
C. G. Musso et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2012)
The role of nitric oxide in the dysregulation of the urine concentration mechanism in diabetes mellitus
Penelope Cipriani et al.
FRONTIERS IN PHYSIOLOGY (2012)
Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice
Timo Rieg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Opposing effects of NaCl restriction and carbohydrate loading on urine volume in diabetic rats
H. A. O'Neill et al.
ACTA PHYSIOLOGICA (2011)
Osteoporosis and risk of fracture in patients with diabetes: an update
Andrea Montagnani et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2011)
Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1
Renato O. Crajoinas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Reciprocal Regulation of Aquaporin-2 Abundance and Degradation by Protein Kinase A and p38-MAP Kinase
Pavel I. Nedvetsky et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats
Sungjin Chung et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus
B. Komoroski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure
Punniyakoti T. Veeraveedu et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Role of vasopressin in diabetes mellitus-induced changes in medullary transport proteins involved in urine concentration in Brattleboro rats
DG Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
分享论文
